Ana Balcazar
Adult Health · Miami, FLNPI 1134402209
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,800 of the $10,683 with a category attached, or 73.0%. GSK accounts for 77.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2021 at $6,952 and has fallen 90.9% since, to $635 in 2025. Among adult health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $71.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$8K
- AstraZeneca$748
- Amgen$291
- AbbVie$265
- Lilly USA, LLC$220
- Boehringer Ingelheim$164
- plus $765 from 12 others
What the payments were for
- Speaking & faculty fees$7,80073%
- Food & beverage$2,88327%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 30 | $8,231 |
| AstraZeneca | 28 | $748 |
| Amgen | 11 | $291 |
| AbbVie | 17 | $265 |
| Lilly USA, LLC | 15 | $220 |
| Boehringer Ingelheim | 7 | $164 |
| Novartis | 8 | $151 |
| Johnson & Johnson | 9 | $141 |
| Novo Nordisk | 7 | $132 |
| Bayer | 4 | $102 |
| Abbott | 3 | $62 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Astellas Pharma US Inc | 2 | $29 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Exact Sciences | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$7,922
- Repatha$136
- AIRSUPRA$120
- BREZTRI$103
How this compares
$10,683 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 39 | $37,608 |
| Novolog FlexpenInsulin Aspart | 14 | $1,976 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $488 |
| Famotidine | 17 | $431 |
| Omeprazole | 18 | $388 |
| Metronidazole | 20 | $365 |
| Fluticasone Propionate | 18 | $337 |
| Atorvastatin Calcium | 36 | $334 |
| Gabapentin | 30 | $288 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 11 | $260 |
| Diclofenac Sodium | 11 | $243 |
| Methylprednisolone | 18 | $159 |
| Losartan Potassium | 28 | $140 |
| Azithromycin | 40 | $140 |
| Meclizine Hcl | 20 | $137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $132 | $37,60839 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,237 adult health providers in Florida.
Other adult health in Miami
- Norma SolisMiami$150K
- Jeffrey HernandezMiami$122K
- Kristen NievesMiami$16K
- Jose ChamorroMiami$15K
- Wendy KaysMiami$13K
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Ashley PontenbergWinter Park$136K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.